Breaking News

IriSys Wins $14.4M NCATS Contract

To provide research services to support the development, manufacture, and stability studies of therapeutics

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

IriSys, LLC, a San Diego-based provider of pharmaceutical product development and manufacturing services, has been awarded a new “CRO Support for Drug Product Development, Manufacture, and Stability Studies” contract by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). The contract, valued at $14.4 million, runs from August 1, 2017 through July 31, 2022. NCATS studies and supports translational science, supporting collab...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters